CD24 antibody treatment improved the phagocytosis of patient-derived mantle cell lymphoma (MCL) cells by macrophages but was less effective in diffuse large B-cell lymphoma (DLBCL) [64]. This evidence concerns the gene CD24 and diffuse large B-cell lymphoma.